Japanese Encephalitis (JE): Population at Risk and Strategies to Control in India
Keywords:
Japanese Encephalitis, Vaccination, ImmunizationAbstract
Currently, an estimated 3 billion people live in the 24 countries, mainly in the WHO South-East Asia and Western Pacific Regions, considered at risk of JE. The case-fatality rate can be as high as 30%, with 20-30% of survivors suffering permanent intellectual, behavioral, or neurological problems. Overall annual incidence in endemic countries has been estimated at 5.4/100000 in the 0–14 year age group, and 0.6/100000 in those aged more than 15years.In lack of convincing data on actual disease burden due to inappropriate diagnostic facilities and strong quality surveillance mechanism for the virus in India, some researchers has shown there concern to continue a national program to control a highly localized illness with around 1000 cases and 200 odd deaths every year.
Immunization as well as other strategies like periodic fogging, promotion of personnel protective measure (protective clothing, use of mats/coils/repellant/aerosol and establishment of paediat- ric Intensive care unit in endemic districts has been advocated since long. Presently out of total 231 JE endemic districts across 22 states, campaign activity has been completed in 230 districts and JE vac- cination has been started as a part of routine immunization. In last few years cases of adult Japanese encephalitis has been reported from identified JE endemic districts.Accordingly, 31 endemic dis- tricts were identified across 3 states where adult JE vaccination campaigns were recommended. The adult JE campaign, covering adults aged 15-65 years, have been completed in these 31 districts wherein 33 million adults were vaccinated against JE.
References
Background paper on JE Vaccines- SAGE working group. Available at http://www.who.int/immunization/sage/ meetings/2014/october/1_JE_Vaccine_Background_Paper. pdf?ua=1, accessed November 2014.
Griffiths MJ et al. Japanese encephalitis virus infection. In Tselis A, Booss J, editors. Handbook of Clinical Neurology. Vol 123 (3rd series) Neurovirology, pp. 551–576.
Shlim DR, Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis. 2002 Jul 15;35(2):183-8. Epub 2002 Jun 19.
Campbell GL et al. Estimated global incidence of Japanese encephalitis: a systematic review.Bull World Health Organ. 2011;89(10):766–774.
Mathers CD et al. Measuring the burden of neglected tropi- cal diseases: the global burden of disease framework. PLoS Negl Trop Dis,2007;1(2) e114.
Hossain MJ et al. Hospital-based surveillance for Japanese encephalitis at four sites in Bangladesh,2003-2005. Am J Trop Med Hyg, 2010;82(2):344–349.
Operational Guidelines: National Programme for Preven- tion and Control of Japanese Encephalitis/ Acute Encephali- tis Syndrome, Government of India, Ministry of Health & Family Welfare, Directorate General of Health Services, Na- tional Vector Borne Disease Control Programme, 2014.
Liu W et al. Risk factors for Japanese encephalitis: a case- control study. Epidemiol Infect, 2010;138(9):1292–1297.
Partridge J et al. Endemic Japanese encephalitis in the Kathmandu valley, Nepal. Am J Trop Med Hyg. 2007; 77(6): 1146–1149.
Kumari R et al. First indigenous transmission of Japanese Encephalitis in urban areas of National Capital Territory of Delhi, India. Trop Med Int Health. 2013;18(6):743–749.
Operational Guide, Japanese Encephalitis Vaccination in India, MOHFW October 2014.
Vashishtha VM, Ramachandran VG. Vaccination Policy for Japanese Encephalitis in India: Tread with Caution!. Indian Pediatr. 2015 Oct;52(10):837-839.
Group of Ministers (GoM) vide Cabinet Secretariat’s order no. 241/1/5/2011-CAB dated 4th November, 2011 by Govt. of India.
Minutes of National Technical Advisory Group on Immun- ization: Standing Technical Sub-Committee meeting De- cember 17th, 2013.
Directorate of National Vector Borne Disease Control Pro- gram- Delhi. Details of AES/JE Cases and Deaths from 2008-2014. Available from: http://nvbdcp.gov.in/Doc/ jeaes-cd-May15.pdf. Accessed Jan 8, 2018.
Group of Ministers (GoM) vide Cabinet Secretariat’s order no. 241/1/5/2011-CAB dated 4th November, 2011 by Govt. of India.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.